Georgetown University
๐ฌ๐นGuatemala
- Country
- ๐ฌ๐นGuatemala
- Ownership
- Private
- Established
- 1789-01-23
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.georgetown.edu
VX-853 in Treating Patients With Solid Tumors Who Are Receiving Liposomal Doxorubicin
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2004-05-25
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 45
- Registration Number
- NCT00004030
- Locations
- ๐บ๐ธ
Vincent T. Lombardi Cancer Research Center, Georgetown University, Washington, District of Columbia, United States
Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors
Phase 2
Completed
- Conditions
- Esophageal CancerPancreatic CancerUnspecified Adult Solid Tumor, Protocol SpecificGastric CancerLung CancerBreast Cancer
- First Posted Date
- 2004-04-14
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 24
- Registration Number
- NCT00003125
- Locations
- ๐บ๐ธ
Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States
๐บ๐ธNational Naval Medical Center, Bethesda, Maryland, United States
Doxorubicin and Paclitaxel in Treating Women With Locally Advanced Breast Cancer
Phase 2
Completed
- Conditions
- Breast Cancer
- First Posted Date
- 2004-02-19
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 40
- Registration Number
- NCT00003035
- Locations
- ๐บ๐ธ
Lombardi Cancer Center, Washington, District of Columbia, United States
Exemestane and Celecoxib in Postmenopausal Women at High Risk for Breast Cancer
Phase 2
Completed
- Conditions
- Breast Neoplasms
- Interventions
- First Posted Date
- 2003-11-17
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 46
- Registration Number
- NCT00073073
- Locations
- ๐บ๐ธ
Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, United States
๐บ๐ธNational Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Epirubicin Plus Irinotecan in Treating Patients With Advanced Cancer
Phase 1
Completed
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-03-24
- Lead Sponsor
- Georgetown University
- Registration Number
- NCT00020748
- Locations
- ๐บ๐ธ
Lombardi Cancer Center at Georgetown University Medical Center, Washington, District of Columbia, United States
Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis
Not Applicable
Completed
- Conditions
- End Stage Renal DiseaseHyperhomocysteinemia
- First Posted Date
- 1999-10-19
- Last Posted Date
- 2015-03-25
- Lead Sponsor
- Georgetown University
- Target Recruit Count
- 84
- Registration Number
- NCT00004495
- Locations
- ๐บ๐ธ
Georgetown University Medical Center, Washington, District of Columbia, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath